Clinical Trial Update: Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

This entry reports an ongoing Phase 2/3 clinical trial evaluating intracoronary infusion of bone marrow-derived mononuclear cells in patients with large acute m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• bone marrow-derived mononuclear cells

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Myocardial Infarction | Phase 2, Phase 3 | Status: UNKNOWN